Melanie Ivarsson OBE Joins PhaseV as Advisor to Propel AI-Driven Clinical Development PhaseV welcomes Melanie Ivarsson OBE to its scientific advisory board, enhancing its AI-driven clinical development capabilities and expertise.

Melanie Ivarsson OBE Joins PhaseV as Advisor to Propel AI-Driven Clinical Development #USA #Boston #PhaseV #AI_Clinical_Trials #Melanie_Ivarsson

PhaseV Secures $50M in Series A Funding to Revolutionize AI in Clinical Trials PhaseV has successfully completed a $50 million Series A funding round to enhance its AI platform for clinical development, supported by major investors and pharma clients.

PhaseV Secures $50M in Series A Funding to Revolutionize AI in Clinical Trials #USA #Boston #PhaseV #Series_A_Funding #AI_Clinical_Trials